Finance

Beta
Lists
SLS:NASDAQ
Sellas Life Sciences Group Inc
$8.14
-2.22%
(-0.18) 1D
Jun 3, 3:16:15 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLS...
Open
$8.12
High
$8.28
Low
$7.85
Mkt. cap
1.52B
Avg. vol.
9.01M
Volume
6.07M
52-wk high
$9.51
52-wk low
$1.39
EPS
-$0.23
Beta
2.50
Shares outstanding
186.03M
No. of employees
13
Open
$8.12
High
$8.28
Low
$7.85
Mkt. cap
1.52B
Avg. vol.
9.01M
Volume
6.07M
52-wk high
$9.51
52-wk low
$1.39
EPS
-$0.23
Beta
2.50
Shares outstanding
186.03M
No. of employees
13
News stories
From sources across the web
About Sellas Life Sciences Group Inc
CEOAngelos M. Stergiou
Employees13
Founded2006
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.87M
4.22M
4.73M
5.13M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.00M
2.87M
2.42M
4.12M
Operating expense
6.87M
7.08M
7.16M
9.25M
Total operating expenses
6.87M
7.08M
7.16M
9.25M
Operating income
-6.87M
-7.08M
-7.16M
-9.25M
Other non operating income
-
-
-
-
EBT including unusual items
-6.60M
-6.79M
-7.66M
-8.41M
EBT excluding unusual items
-6.60M
-6.79M
-6.56M
-8.41M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.60M
-6.79M
-7.66M
-8.41M
Net profit margin
-
-
-
-
Earnings per share
-0.07
-0.06
-0.05
-0.05
Interest and investment income
272.00K
292.00K
597.00K
845.00K
Interest expense
-
-
-
-
Net interest expenses
272.00K
292.00K
597.00K
845.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more